MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
MapLight Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.00+0.30 (+3.90%)
Close on Oct 19, 2026
- Market cap
- $363.45M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
MapLight Therapeutics has not reported a dividend
No dividend per share appears in MapLight Therapeutics's annual filings since fiscal 2023.